Article Information
History
- September 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Justin L Roncaioli1,
- Janet Peace Babirye1,
- Roberto A Chavez1,
- Fitty L Liu1,
- Elizabeth A Turcotte1,
- Angus Y Lee5,
- Cammie F Lesser2,3,4 and
- Russell E Vance1,5,6,7,*
- 1Division of Immunology & Molecular Medicine, Department of Molecular & Cell Biology, University of California, Berkeley, Berkeley, United States
- 2Department of Microbiology, Harvard Medical School, Boston, United States
- 3Broad Institute of Harvard and MIT, Cambridge, United States
- 4Department of Medicine, Division of Infectious Diseases, Massachusetts General Hospital, Boston, United States
- 5Cancer Research Laboratory, University of California, Berkeley, Berkeley, United States
- 6Immunotherapeutics and Vaccine Research Initiative, University of California, Berkeley, Berkeley, United States
- 7Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States
- ↵*Correspondence: rvance{at}berkeley.edu
Posted September 21, 2022.
A hierarchy of cell death pathways confers layered resistance to shigellosis in mice
